Latest Financial Performance News

SIV Capital Limited reported a sharp increase in losses for the half-year ending December 2024 and remains suspended from ASX trading due to operational concerns. The company is exploring acquisitions to leverage substantial tax losses and restore market confidence.

Argenica Therapeutics reported a 16% reduction in half-year losses to $1.19 million, buoyed by a 29% increase in other income largely from R&D tax incentives, as it advances its neuroprotective drug development.

Computershare Limited reported a 6.7% decline in revenue to $1.5 billion for the half-year ended December 2024, primarily due to the sale of its US Mortgage Services business. However, profit after tax from continuing operations surged 24.9% to $286.5 million, underpinning an interim dividend of AU 45 cents per share.

Tamawood Limited has reported a steady increase in revenue and profit for the half year ended December 31, 2024, signaling ongoing resilience in the residential construction sector.

Ryder Capital Limited reports a robust $13.02 million total comprehensive income for 1H FY25, driving a 12.5% increase in its fully franked interim dividend to 4.5 cents per share.

Ryder Capital Limited has reported a striking 312% increase in total comprehensive income for the half-year ended December 31, 2024, alongside a 12.5% hike in its fully franked interim dividend, underscoring robust portfolio performance amid market uncertainties.

VGI Partners Global Investments reported a steep $43.1 million loss for the half-year ending December 2024 but announced an increased fully franked interim dividend and expanded share buy-back program.

Resouro Strategic Metals Inc. posted a $5.28 million net loss for the nine months ended December 31, 2024, reflecting increased exploration and administrative expenses as it advances its Tiros Titanium and Rare Earth Elements Project. The company bolstered its balance sheet with a successful ASX dual listing and private placements but faces ongoing challenges to sustain operations.

SomnoMed Limited prepares to unveil its H1FY25 financial results on February 28, 2025, accompanied by a live investor presentation and Q&A session. The company remains a global leader in sleep apnea treatment solutions.

Ramsay Health Care has announced a significant $305 million impairment in its UK segment driven by challenges at Elysium, alongside a $64.5 million tax provision release linked to Ramsay Santé. The company is taking decisive steps to address operational weaknesses while its core UK hospitals show promising growth.

Charter Hall Social Infrastructure REIT delivered a solid 2025 half-year performance, maintaining distribution guidance while enhancing its portfolio through key acquisitions and divestments. The REIT’s outlook brightens with an increased full-year distribution forecast.

Charter Hall Social Infrastructure REIT reported solid half-year results for 1H FY25, underpinned by strong earnings, active portfolio management, and an upgraded distribution guidance. The REIT’s acquisition of a high-yield pathology laboratory and divestment of childcare assets highlight its strategic repositioning.